Article Information
vol. 9 no. 406
- Received for publication October 25, 2016
- Resubmitted March 15, 2017
- Accepted for publication August 14, 2017
- .
Author Information
- Boris Julg1,2,*,
- Lawrence J. Tartaglia2,*,
- Brandon F. Keele3,
- Kshitij Wagh4,
- Amarendra Pegu5,
- Devin Sok6,
- Peter Abbink2,
- Stephen D. Schmidt5,
- Keyun Wang5,
- Xuejun Chen5,
- M. Gordon Joyce5,
- Ivelin S. Georgiev5,
- Misook Choe5,
- Peter D. Kwong5,
- Nicole A. Doria-Rose5,
- Khoa Le6,
- Mark K. Louder5,
- Robert T. Bailer5,
- Penny L. Moore7,8,
- Bette Korber4,
- Michael S. Seaman2,
- Salim S. Abdool Karim8,9,
- Lynn Morris7,8,
- Richard A. Koup5,
- John R. Mascola5,
- Dennis R. Burton1,6 and
- Dan H. Barouch1,2,†
- 1Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University, Cambridge, MA 02139, USA.
- 2Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA 02115, USA.
- 3AIDS and Cancer Virus Program, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.
- 4Los Alamos National Laboratory, Los Alamos, NM 87545, USA.
- 5Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20814, USA.
- 6The Scripps Research Institute, La Jolla, CA 92037, USA.
- 7National Institute for Communicable Diseases of the National Health Laboratory Service and the University of the Witwatersrand, 2131 Johannesburg, South Africa.
- 8Centre for the AIDS Programme of Research in South Africa, 4013 Durban, South Africa.
- 9Columbia University, New York, NY 10032, USA.
- ↵†Corresponding author. Email: dbarouch{at}bidmc.harvard.edu